SIPI focuses on medicine industry
February 23rd, 2009
Though SIPI may sell its crown jewel, its share price still rises. The upward trend of SIPI’s shares is due to its sales with Brilliance Group on Feb 6.
After hitting the peak point of 14.15 yuan last Friday, SIPI shares ended with 13.21 yuan a share.
Approved by the shareholders of SIPI, the 1.06 billion yuan’s sale between its subsidiary and Brillance will be helpful for its core pharmaceutical business. It is said that SIPI’s subsidiary has owned 21.17% stake in Hong Kong-listed Lianhua. Read more…
Popularity: 3% [?]